Skip to main content
Clinical Trials/ACTRN12614000857606
ACTRN12614000857606
Recruiting
Not Applicable

Changes in exercise capacity, inflammation and endothelial function following cardioversion in asymptomatic versus symptomatic persistent atrial fibrillation

Centre for Heart Rhythm Disorders0 sites70 target enrollmentAugust 8, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Centre for Heart Rhythm Disorders
Enrollment
70
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 8, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Centre for Heart Rhythm Disorders

Eligibility Criteria

Inclusion Criteria

  • Persistent AF, defined as an episode of AF lasting longer than 7 days or lasts \<7 days and requires direct cardioversion.
  • Rate controlled during AF with resting ventricular rate less than 110bpm.
  • Able and willing to provide written informed consent to participate.

Exclusion Criteria

  • Patients contraindicated for exercise testing according to American Heart Association guidelines.
  • Paroxysmal (AF duration \<7 days) or Permanent AF (AF duration \>1 year).
  • Decompensated heart failure
  • Unstable angina.
  • Hemodynamic instability defined as systolic blood pressure less than 90mmHg.
  • Previous AF ablation
  • Pregnancy or suspected pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials